Publications by Birgitte Smith-Sørensen
28 publications found
Original articles
Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
Br J Cancer, 88 (12), 1995-2001
DOI 10.1038/sj.bjc.6600998, PubMed 12799648
Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance
BMC Genomics, 4 (1), 11
DOI 10.1186/1471-2164-4-11, PubMed 12659661
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
Oncogene, 21 (57), 8878-84
DOI 10.1038/sj.onc.1205978, PubMed 12483540
MArray: analysing single, replicated or reversed microarray experiments
Bioinformatics, 18 (8), 1139-40
DOI 10.1093/bioinformatics/18.8.1139, PubMed 12176840
Analysis of repeatability in spotted cDNA microarrays
Nucleic Acids Res, 30 (14), 3235-44
DOI 10.1093/nar/gkf441, PubMed 12136105
Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods
Curr Protoc Hum Genet, Chapter 7, Unit 7.4
DOI 10.1002/0471142905.hg0704s15, PubMed 18428305
Detection of mutations by denaturing gradient gel electrophoresis
Curr Protoc Hum Genet, Chapter 7, Unit 7.5
DOI 10.1002/0471142905.hg0705s17, PubMed 18428306
Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors
Genes Chromosomes Cancer, 30 (2), 202-6
DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1079>3.0.CO;2-5, PubMed 11135438
No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines
Int J Radiat Biol, 75 (9), 1149-60
DOI 10.1080/095530099139629, PubMed 10528923
TP53 as a predictor of response to chemotherapy in breast cancer
ESO SCI UPDATES, 4, 73-88
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status
Br J Cancer, 78 (3), 375-81
DOI 10.1038/bjc.1998.502, PubMed 9703286
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
Nat Med, 2 (7), 811-4
DOI 10.1038/nm0796-811, PubMed 8673929
Functional analysis of Burkitt's lymphoma mutant c-Myc proteins
J Biol Chem, 271 (10), 5513-8
DOI 10.1074/jbc.271.10.5513, PubMed 8621409
CDKN2A (p16INK4A) somatic and germline mutations
Hum Mutat, 7 (4), 294-303
DOI 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9, PubMed 8723678
Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection
Hum Mutat, 5 (1), 48-57
DOI 10.1002/humu.1380050107, PubMed 7728149
Database of p53 gene somatic mutations in human tumors and cell lines
Nucleic Acids Res, 22 (17), 3551-5
PubMed 7937055
Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma
J Clin Oncol, 12 (5), 925-30
DOI 10.1200/JCO.1994.12.5.925, PubMed 8164043
Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE)
Hum Mutat, 2 (4), 274-85
DOI 10.1002/humu.1380020407, PubMed 8401536
Detection of DNA variation in cancer
Pharmacogenetics, 2 (6), 317-28
DOI 10.1097/00008571-199212000-00011, PubMed 1306133
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)
Mutat Res, 269 (1), 41-53
DOI 10.1016/0027-5107(92)90159-y, PubMed 1381470
No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lung
Genes Chromosomes Cancer, 5 (2), 97-103
DOI 10.1002/gcc.2870050202, PubMed 1381957
Screening for germ line TP53 mutations in breast cancer patients
Cancer Res, 52 (11), 3234-6
PubMed 1591732
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
Proc Natl Acad Sci U S A, 88 (19), 8405-9
DOI 10.1073/pnas.88.19.8405, PubMed 1924299
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection
Mutat Res, 263 (1), 61
DOI 10.1016/0165-7992(91)90036-4, PubMed 2034242
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection
Mutat Res, 262 (1), 63-71
DOI 10.1016/0165-7992(91)90108-g, PubMed 1702518
Screening for base mutations in the PAH and HPRT loci using the polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE)
Prog Clin Biol Res, 340A, 389-98
PubMed 2388921
Theses
Alterations in the cancer associated genes TP53, CDKN2A, and c-MYC,: development of mutation detection and some functional aspects
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 981422462, ISBN 82-7633-100-9
Mutasjonsanalyser i HPRT-genet: bruk av PCR i kombinasjon med DGGE
[B. Smith-Sørensen], Oslo, 133 s.
BIBSYS 900162333